| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.029 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |